Christine Bellon - Mar 30, 2023 Form 4 Insider Report for Beam Therapeutics Inc. (BEAM)

Role
Chief Legal Officer
Signature
By: /s/ Christine Bellon
Stock symbol
BEAM
Transactions as of
Mar 30, 2023
Transactions value $
$64,554
Form type
4
Date filed
3/31/2023, 07:51 PM
Previous filing
Mar 27, 2023
Next filing
Apr 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BEAM Common Stock Options Exercise $45.3K +6.27K +10.73% $7.22 64.7K Mar 30, 2023 Direct
transaction BEAM Common Stock Options Exercise $19.3K +2.67K +4.12% $7.22 67.4K Mar 30, 2023 Direct
transaction BEAM Common Stock Award $0 +17.5K +25.97% $0.00 84.9K Mar 31, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BEAM Stock Option (Right to Buy) Options Exercise $0 -6.27K -31.44% $0.00 13.7K Mar 30, 2023 Common Stock 6.27K $7.22 Direct F2
transaction BEAM Stock Option (Right to Buy) Options Exercise $0 -2.67K -13.75% $0.00 16.7K Mar 30, 2023 Common Stock 2.67K $7.22 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") granted to the Reporting Person under the Beam Therapeutics Inc. ("BEAM") 2019 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of BEAM's common stock. The RSUs vest in four substantially equal annual installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service with BEAM through each vesting date.
F2 This stock option vests as to 25% on the first anniversary of the vesting commencement date, May 16, 2020, and at a rate of 2.78% each month thereafter until the option is fully vested.
F3 This stock option vests as to 25% on the first anniversary of the vesting commencement date, May 17, 2020, and at a rate of 2.78% each month thereafter until the option is fully vested.